35525984|t|AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology.
35525984|a|BACKGROUND: Changes in the expression and activity of the AKT oncogene play an important role in psychiatric disease. We present translational data assessing the role of AKT in psychiatric symptoms. METHODS: (1) We assessed the protein activity of an AKT3 mutant harboring a PH domain mutation (Q60H) detected in a patient with schizophrenia, the corresponding AKT1 mutant (Q61H), and wild-type AKT1 and AKT3 transduced in AKT-null mouse fibroblasts and modeled the Q61H mutation onto the crystal structure of the Akt1 PH domain. (2) We analyzed the results of earlier genome-wide association studies to determine the distribution of schizophrenia-associated single-nucleotide polymorphisms (SNPs) in the AKT3 gene. (3) We analyzed the psychiatric adverse events (AEs) of patients treated with M2698 (p70S6K/AKT1/AKT3 inhibitor) and with other PI3K/AKT/mTOR pathway inhibitors. RESULTS: (1) Proteins encoded by AKT3 (AKT3Q60H) and AKT1 (AKT1Q61H) mutants had lower kinase activity than those encoded by wild-type AKT3 and AKT1, respectively. Molecular modeling of the AKT1-Q61H mutant suggested conformational changes that may reduce the binding of D3-phosphorylated phosphoinositides to the PH domain. (2) We identified multiple SNPs in the AKT3 gene that were strongly associated with schizophrenia (p < 0.5 x 10-8). (3) Psychiatric AEs, mostly insomnia, anxiety, and depression, were noted in 29% of patients treated with M2698. In randomized studies, their incidence was higher in PI3K/AKT/mTOR inhibitor arms compared with placebo arms. All psychiatric AEs were reversible. CONCLUSIONS: Our data elucidate the incidence and mechanisms of psychiatric AEs in patients treated with PI3K/AKT/mTOR inhibitors and emphasize the need for careful monitoring.
35525984	0	3	AKT	Gene	207
35525984	84	95	psychiatric	Disease	MESH:D001523
35525984	170	173	AKT	Gene	207
35525984	209	228	psychiatric disease	Disease	MESH:D001523
35525984	282	285	AKT	Gene	207
35525984	289	309	psychiatric symptoms	Disease	MESH:D001523
35525984	363	367	AKT3	Gene	10000
35525984	407	411	Q60H	ProteinMutation	tmVar:p|SUB|Q|60|H;HGVS:p.Q60H;VariantGroup:0;CorrespondingGene:10000;RS#:761062123;CorrespondingSpecies:9606;CA#:1484161
35525984	427	434	patient	Species	9606
35525984	440	453	schizophrenia	Disease	MESH:D012559
35525984	473	477	AKT1	Gene	207
35525984	486	490	Q61H	ProteinMutation	tmVar:p|SUB|Q|61|H;HGVS:p.Q61H;VariantGroup:1;CorrespondingGene:207;CorrespondingSpecies:9606
35525984	507	511	AKT1	Gene	207
35525984	516	520	AKT3	Gene	10000
35525984	535	538	AKT	Gene	11651
35525984	544	549	mouse	Species	10090
35525984	578	582	Q61H	ProteinMutation	tmVar:p|SUB|Q|61|H;HGVS:p.Q61H;VariantGroup:1;CorrespondingGene:207;CorrespondingSpecies:9606
35525984	626	630	Akt1	Gene	207
35525984	746	759	schizophrenia	Disease	MESH:D012559
35525984	817	821	AKT3	Gene	10000
35525984	848	874	psychiatric adverse events	Disease	MESH:D064420
35525984	884	892	patients	Species	9606
35525984	906	911	M2698	Chemical	MESH:C000722774
35525984	913	919	p70S6K	Gene	6198
35525984	920	924	AKT1	Gene	207
35525984	925	929	AKT3	Gene	10000
35525984	961	964	AKT	Gene	207
35525984	965	969	mTOR	Gene	2475
35525984	1023	1027	AKT3	Gene	10000
35525984	1029	1033	AKT3	Gene	10000
35525984	1033	1037	Q60H	ProteinMutation	tmVar:p|SUB|Q|60|H;HGVS:p.Q60H;VariantGroup:0;CorrespondingGene:10000;RS#:761062123;CorrespondingSpecies:9606;CA#:1484161
35525984	1043	1047	AKT1	Gene	207
35525984	1125	1129	AKT3	Gene	10000
35525984	1134	1138	AKT1	Gene	207
35525984	1180	1184	AKT1	Gene	207
35525984	1185	1189	Q61H	ProteinMutation	tmVar:p|SUB|Q|61|H;HGVS:p.Q61H;VariantGroup:1;CorrespondingGene:207;CorrespondingSpecies:9606
35525984	1279	1296	phosphoinositides	Chemical	MESH:D010716
35525984	1354	1358	AKT3	Gene	10000
35525984	1399	1412	schizophrenia	Disease	MESH:D012559
35525984	1435	1450	Psychiatric AEs	Disease	MESH:D064420
35525984	1459	1467	insomnia	Disease	MESH:D007319
35525984	1469	1476	anxiety	Disease	MESH:D001007
35525984	1482	1492	depression	Disease	MESH:D003866
35525984	1515	1523	patients	Species	9606
35525984	1537	1542	M2698	Chemical	MESH:C000722774
35525984	1602	1605	AKT	Gene	207
35525984	1606	1610	mTOR	Gene	2475
35525984	1658	1673	psychiatric AEs	Disease	MESH:D064420
35525984	1755	1770	psychiatric AEs	Disease	MESH:D064420
35525984	1774	1782	patients	Species	9606
35525984	1801	1804	AKT	Gene	207
35525984	1805	1809	mTOR	Gene	2475
35525984	Positive_Correlation	MESH:D001523	RS#:761062123;HGVS:p.Q60H;CorrespondingGene:10000
35525984	Positive_Correlation	MESH:D001523	HGVS:p.Q61H;CorrespondingGene:207
35525984	Association	MESH:D001523	207
35525984	Association	MESH:D001007	207
35525984	Positive_Correlation	MESH:C000722774	MESH:D003866
35525984	Positive_Correlation	MESH:C000722774	MESH:D001007
35525984	Association	MESH:D003866	207
35525984	Association	MESH:D012559	RS#:761062123;HGVS:p.Q60H;CorrespondingGene:10000
35525984	Negative_Correlation	MESH:C000722774	10000
35525984	Negative_Correlation	MESH:C000722774	6198
35525984	Association	MESH:D012559	207
35525984	Positive_Correlation	MESH:C000722774	MESH:D064420
35525984	Positive_Correlation	MESH:C000722774	MESH:D007319
35525984	Association	MESH:D064420	2475
35525984	Association	MESH:D007319	207
35525984	Association	MESH:D012559	10000
35525984	Association	207	6198
35525984	Association	MESH:D001523	10000
35525984	Association	MESH:D001523	207
35525984	Association	MESH:D012559	10000

